Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea, in 2015
10.5365/wpsar.2018.9.3.002
- Author:
Boyeong Ryu
1
,
2
;
Sung-Il Cho
1
,
2
;
Myoung-don Oh
1
,
3
;
Jong-Koo Lee
1
,
4
;
Jaein Lee
5
;
Young-Ok Hwang
5
;
Jeong-Sun Yang
6
;
Sung Soon Kim
6
;
Ji Hwan Bang
1
,
7
Author Information
1. Seoul Center for Infectious Disease Control and Prevention, Seoul, Republic of Korea
2. Department of Epidemiology, Seoul National University School of Public Health, Seoul, Republic of Korea
3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
4. Department of Family Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
5. Seoul Metropolitan Government Research Institute of Public Health and Environment, Seoul, Republic of Korea
6. Korea Centers for Disease Control and Prevention, Cheongju, Republic of Korea
7. Division of Infectious Diseases, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea
- Publication Type:Journal Article
- Keywords:
MERS-CoV;
seroprevalence study;
Republic of Korea;
MERS outbreak;
public health responders
- From:
Western Pacific Surveillance and Response
2019;10(2):46-48
- CountryWHO-WPRO
- Language:English
-
Abstract:
The first case of Middle East respiratory syndrome coronavirus (MERS-CoV) in the Republic of Korea was confirmed in May 2015 after a traveller returned from the Middle East. There were 186 cases, including 38 deaths, within two months. The potential of a single MERS-confirmed patient to result in such a large MERS outbreak constitutes a serious global health concern.
- Full text:wpsar.2019.10.2-046.pdf
